Genetic Testing for Psychiatric Medications 2025
Published 03/03/2025
At AttoDiagnostics, our pharmacogenomics test covers over 20 conditions and 115 medications. Within the psychiatric space, depression, anxiety, bipolar disorder, schizophrenia, and ADHD are the main conditions we focus on. The benefits of PGx affect not only the patients directly, in terms faster and better treatment outcomes, but also UK as a whole: Using DNA-driven prescriptions could prevent 15% of hospital admissions, saving the NHS £530 annually.